Association between delay in diabetes development and mortality in people with obesity: Up to 33 years follow-up of the prospective Swedish Obese Subjects study.

Autor: Carlsson LMS; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Carlsson B; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), and Late-Stage Development, CVRM, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Jacobson P; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Andersson-Assarsson JC; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Karlsson C; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), and Late-Stage Development, CVRM, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Kristensson FM; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Oncology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden., Ahlin S; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Region Västra Götaland, NU Hospital Group, Department of Clinical Physiology, Trollhättan, Sweden., Näslund I; Department of Surgery, Faculty of Medicine and Health, Örebro University, Örebro, Sweden., Karason K; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Svensson PA; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Institute of Health and Care Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Taube M; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Peltonen M; Finnish Institute for Health and Welfare, Helsinki, Finland., Sjöholm K; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Publikováno v: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Oct 21. Date of Electronic Publication: 2024 Oct 21.

Breast Cancer Risk After Bariatric Surgery and Influence of Insulin Levels: A Nonrandomized Controlled Trial.

Autor: Kristensson FM; Institute of Medicine, Department of Molecular and Clinical Medicine, the Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.; Department of Surgery, Region Västra Götaland, Sahlgrenska University Hospital/Östra, Gothenburg, Sweden., Andersson-Assarsson JC; Institute of Medicine, Department of Molecular and Clinical Medicine, the Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden., Peltonen M; Finnish Institute for Health and Welfare, Helsinki, Finland., Jacobson P; Institute of Medicine, Department of Molecular and Clinical Medicine, the Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden., Ahlin S; Institute of Medicine, Department of Molecular and Clinical Medicine, the Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.; Department of Clinical Physiology, Region Västra Götaland, NU Hospital Group, Trollhättan, Sweden., Svensson PA; Institute of Medicine, Department of Molecular and Clinical Medicine, the Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.; Institute of Health and Care Sciences, the Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden., Sjöholm K; Institute of Medicine, Department of Molecular and Clinical Medicine, the Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden., Carlsson LMS; Institute of Medicine, Department of Molecular and Clinical Medicine, the Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden., Taube M; Institute of Medicine, Department of Molecular and Clinical Medicine, the Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.

Publikováno v: JAMA surgery [JAMA Surg] 2024 Aug 01; Vol. 159 (8), pp. 856-863.

Non-alcohol substance use disorder after bariatric surgery in the prospective, controlled Swedish Obese Subjects study.

Autor: Svensson PA; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.; Institute of Health and Care Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden., Peltonen M; Chronic Disease Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland., Andersson-Assarsson JC; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden., Ahlin S; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.; Region of Västra Götaland, NU Hospital Group, Department of Clinical Physiology, Trollhättan, Sweden., Brembeck P; Institute of Health and Care Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden., Engström M; Institute of Health and Care Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.; Department of Surgery, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden., Jacobson P; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden., Taube M; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden., Sjöholm K; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden., Carlsson LMS; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.

Publikováno v: Obesity (Silver Spring, Md.) [Obesity (Silver Spring)] 2023 Aug; Vol. 31 (8), pp. 2171-2177.

Life expectancy after bariatric surgery or usual care in patients with or without baseline type 2 diabetes in Swedish Obese Subjects.

Autor: Carlsson LMS; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Carlsson B; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Jacobson P; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Karlsson C; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Late-Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Andersson-Assarsson JC; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Kristensson FM; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Region Västra Götaland, Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden., Ahlin S; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Region Västra Götaland, Department of Clinical Physiology, NU Hospital Group, Trollhättan, Sweden., Svensson PA; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Institute of Health and Care Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Taube M; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Näslund I; Department of Surgery, Faculty of Medicine and Health, Örebro University, Örebro, Sweden., Karason K; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Peltonen M; Finnish Institute for Health and Welfare, Helsinki, Finland., Sjöholm K; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. kajsa.sjoholm@medic.gu.se.

Publikováno v: International journal of obesity (2005) [Int J Obes (Lond)] 2023 Oct; Vol. 47 (10), pp. 931-938. Date of Electronic Publication: 2023 Jul 12.

Fracture risk after three bariatric surgery procedures in Swedish obese subjects: up to 26 years follow-up of a controlled intervention study.

Autor: Ahlin S; From the, Department of Molecular and Clinical Medicine, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Internal Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy., Peltonen M; Department of Chronic Disease Prevention, National Institute of Health and Welfare, Helsinki, Finland., Sjöholm K; From the, Department of Molecular and Clinical Medicine, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Anveden Å; From the, Department of Molecular and Clinical Medicine, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Surgery, Halland Hospital, Halmstad, Sweden., Jacobson P; From the, Department of Molecular and Clinical Medicine, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Andersson-Assarsson JC; From the, Department of Molecular and Clinical Medicine, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Taube M; From the, Department of Molecular and Clinical Medicine, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Larsson I; From the, Department of Molecular and Clinical Medicine, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Unit of Clinical Nutrition, Department of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden., Lohmander LS; Faculty of Medicine, Department of Clinical Sciences Lund, Lund University, Orthopedics, Sweden., Näslund I; Department of Surgery, Faculty of Medicine and Health, Örebro University Hospital, Örebro, Sweden., Svensson PA; From the, Department of Molecular and Clinical Medicine, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Institute of Health and Care Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Carlsson LMS; From the, Department of Molecular and Clinical Medicine, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Publikováno v: Journal of internal medicine [J Intern Med] 2020 May; Vol. 287 (5), pp. 546-557. Date of Electronic Publication: 2020 Mar 03.